Hematopoietic/Lymphoid Cancer Recruiting Phase 2 Trials for Blinatumomab (DB09052)

IndicationStatusPhase
DBCOND0030132 (Hematopoietic/Lymphoid Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03121534Study of Blinatumomab in Richter TransformationTreatment